Substituted imidazole derivatives
The present invention relates to new substituted imidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula:
Novartis Vaccines and Diagnostics, Inc.
C C C C C C C C A C C C C C C A C A C C C C
C07D C07D C07D C07D C07D C07D C07D C07D A61P C07D C07D C07D C07D C07D C07D A61P C07D A61P C07D C07D C07D C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Paul A. Weibo Mark Yia Elisa Ryan Savithri Kelly Kris Liana Marie Hong Sabina Rustum Paul A. Vincent P. Kenneth W. Kay Megan C. Tinya Sharadha Annette Eric Nathan Anu Rama Elizabeth David
Renhowe Wang Knapp Xia Jazan Constantine Ramurthy Wayman Mendenhall Lagniton Yang Pecchi Boyce Barsanti Le Bair Huh Phillips Abrams Subramanian Walter Martin Brammeier Sharma Jain Mieuli Duhl